CSIMarket
 


Alaunos Therapeutics Inc   (TCRT)
Other Ticker:  
 

Alaunos Therapeutics Inc 's Quick Ratio

TCRT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




TCRT Quick Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change 16.67 % 96.98 % 11.99 % -16.98 % 64.64 %
Y / Y Cash & cash equivalent Change -58.78 % -21.81 % -31.78 % -43.86 % -40.25 %
Quick Ratio MRQ 1.15 2.24 3.21 4.74 3.26
Overall Ranking # 1892 # 0 # 0 # 0 # 0
Seq. Current Liabilities Change 22.76 % 26.09 % 32.37 % -43.06 % 107.26 %
Seq. Cash & cash equivalent Change -37 % -12.08 % -10.25 % -17.08 % 19.52 %



Quick Ratio third quarter 2022 Comment
Due to increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 1.15 below Alaunos Therapeutics Inc average.

Within Major Pharmaceutical Preparations industry 406 other companies have achieved higher Quick Ratio than Alaunos Therapeutics Inc in third quarter 2022. While Quick Ratio total ranking has deteriorated compare to the prior quarter from 0 to 1892.

Explain Quick Ratio?
What are TCRT Segments?
See Quick Ratio TCRT on the trailing twelve month basis
Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 407
Healthcare Sector # 747
Overall Market # 1892


Quick Ratio Statistics
High Average Low
12.36 5.57 0.53
(Mar 31 2015)   (Sep 30 2018)




Financial Statements
Alaunos Therapeutics Inc 's Current Liabilities $ 33 Millions Visit TCRT's Balance sheet
Alaunos Therapeutics Inc 's Cash & cash equivalent $ 38 Millions Visit TCRT's Balance sheet
Source of TCRT's Sales Visit TCRT's Sales by Geography


Cumulative Alaunos Therapeutics Inc 's Quick Ratio

TCRT's Quick Ratio for the trailling 12 Months

TCRT Quick Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth 16.67 % 96.98 % 11.99 % -16.98 % 64.64 %
Y / Y Cash & cash equivalent TTM Growth -58.78 % -21.81 % -31.78 % -43.86 % -40.25 %
Quick Ratio TTM 2.5 3.21 3.96 4.49 5.05
Total Ranking TTM # 1066 # 1131 # 930 # 739 # 0
Seq. Current Liabilities TTM Growth 22.76 % 26.09 % 32.37 % -43.06 % 107.26 %
Seq. Cash & cash equivalent TTM Growth -37 % -12.08 % -10.25 % -17.08 % 19.52 %


TTM Quick Ratio Comment
On the trailing twelve months basis Due to growth in Current Liabilities in the III. Quarter to $32.87 millions, average cumulative Quick Ratio decreased to 2.5 below the Alaunos Therapeutics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 335 other companies have achieved higher Quick Ratio than Alaunos Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. 1066.

Explain Quick Ratio?
What are TCRT Segments?
See Quick Ratio TCRT on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 336
Healthcare Sector # 595
Within the Market # 1066


TTM Quick Ratio Statistics
High Average Low
8.58 5.36 1.89
(Jun 30 2020)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Arcturus Therapeutics Holdings Inc   3.13 $ 237.676  Millions$ 75.849  Millions
Spero Therapeutics Inc   3.11 $ 50.446  Millions$ 16.225  Millions
Equillium Inc   3.07 $ 44.522  Millions$ 14.509  Millions
Vaxxinity Inc   3.06 $ 99.108  Millions$ 32.431  Millions
Regeneron Pharmaceuticals Inc   3.01 $ 7,021.700  Millions$ 2,332.000  Millions
Immunogen inc   2.99 $ 309.511  Millions$ 103.642  Millions
Beigene Ltd   2.97 $ 4,197.323  Millions$ 1,411.311  Millions
Alnylam Pharmaceuticals Inc   2.90 $ 2,242.278  Millions$ 772.791  Millions
Zymeworks Inc   2.88 $ 166.242  Millions$ 57.706  Millions
Eton Pharmaceuticals Inc   2.87 $ 13.378  Millions$ 4.661  Millions
Harmony Biosciences Holdings inc   2.87 $ 307.763  Millions$ 107.357  Millions
Inmed Pharmaceuticals Inc   2.86 $ 9.393  Millions$ 3.282  Millions
Aptevo Therapeutics Inc   2.84 $ 22.150  Millions$ 7.786  Millions
23andme Holding Co   2.84 $ 410.891  Millions$ 144.906  Millions
Cellectar Biosciences Inc   2.79 $ 17.785  Millions$ 6.367  Millions
Evelo Biosciences Inc   2.79 $ 69.053  Millions$ 24.740  Millions
Mannkind Corporation  2.77 $ 165.046  Millions$ 59.597  Millions
Cti Biopharma Corp   2.74 $ 81.639  Millions$ 29.770  Millions
Scpharmaceuticals Inc   2.73 $ 45.186  Millions$ 16.582  Millions
Clene Inc   2.64 $ 16.233  Millions$ 6.154  Millions
Avadel Pharmaceuticals Plc  2.63 $ 106.475  Millions$ 40.500  Millions
Actinium Pharmaceuticals Inc   2.61 $ 111.815  Millions$ 42.869  Millions
F star Therapeutics Inc   2.57 $ 35.568  Millions$ 13.849  Millions
Sigilon Therapeutics Inc   2.56 $ 78.269  Millions$ 30.555  Millions
Karyopharm Therapeutics Inc   2.53 $ 149.461  Millions$ 58.991  Millions
Nrx Pharmaceuticals Inc   2.52 $ 18.249  Millions$ 7.235  Millions
Pacira Biosciences inc   2.50 $ 328.725  Millions$ 131.526  Millions
Horizon Therapeutics Public Limited Company  2.48 $ 2,135.270  Millions$ 860.614  Millions
Oncorus Inc   2.47 $ 41.568  Millions$ 16.813  Millions
Biomarin Pharmaceutical Inc  2.44 $ 1,273.768  Millions$ 521.020  Millions

Date modified: 2022-11-16T22:21:07+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PLAB's Profile

Stock Price

PLAB's Financials

Business Description

Fundamentals

Charts & Quotes

PLAB's News

Suppliers

PLAB's Competitors

Customers & Markets

Economic Indicators

PLAB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071